Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.

Publikation

Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.

Wissenschaftlicher Artikel/Review - 01.07.2022

Roelcke Ulrich, Schwyzer Lucia, Zeitlberger Anna Maria, Hundsberger Thomas

Zitation

Roelcke U, Schwyzer L, Zeitlberger A, Hundsberger T. Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression. Oncology 2022; 101:145-152.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Oncology 2022; 101

Veröffentlichungsdatum

01.07.2022

eISSN (Online)

1423-0232

Seiten

145-152

Kurzbeschreibung/Zielsetzung

The evaluation of symptom burden, performance status, and neurological function is still challenging in glioblastoma (GBM) patients. Patients may suffer from a wide spectrum of neurological symptoms like cognitive deficits, aphasia, or hemiparesis, which interfere to report to comprehensive questionnaires. However, an integrated and reliable neuro-oncological assessment is the key in the clinical management and in the evaluation of treatment benefits for GBM patients.